Drug price increases have emerged as a core strategy for generic pharmaceutical companies in the recent past. In September last year, Martin Shkreli’s decision to increase the price of Daraprim (Pyrimethamine) from US $ 13.50 per tablet to US $ 750 overnight, received an angry tweet from Hillary Clinton. “Price gouging like this in the specialty drug market is outrageous,” she had tweeted.
Shkreli of Turing Pharmaceuticals wasn’t the only one hiking prices of drugs. ‘Price gouging’ has become a hot topic, and synonymous with the activities of many major pharmaceutical companies.
Price increase due to ownership, not improved science
Valeant Pharmaceuticals, a stock market darling until recently, developed a strategy of buying up companies and dramatically increasing the price of the acquired drugs.
In February 2015, Valeant purchased two life-saving heart drugs – Isuprel and Nitropress. And the same day, Valeant increased the prices of these drugs by 525 percent and 212 percent respectively. The increase was not an outcome of improved science but simply a change of ownership.
Similarly, on January 1, 2016, Pfizer raised prices of more than 100 of its drugs. According to global information services company Wolters Kluwer the price increase was as much as 20 percent in the case of some medicines.
Another recent study on US drug prices uncovered that “prices for four of the nation's top 10 drugs increased more than 100 percent since 2011, Reuters found. Six others went up more than 50 percent.”
“It’s not funny, Mr. Shkreli. People are dying”
Scrutiny on drug price increases and its accounting practices has made Valeant Pharmaceuticals, which not so long ago was the biggest company on the Toronto Stock Exchange (TSX), lose 90 per cent of its market value in less than a year.
“Pharma Bro” Shkreli was arrested in December for allegedly bilking tens of millions of dollars from his former biotech venture, Retrophin.
And while he smirked his way through the Senate hearing on drug price increases, he was rebuked by Representative Elijah Cummings. “It’s not funny, Mr. Shkreli. People are dying, and they are getting sicker and sicker,” he told Shkreli, as the latter grinned during the Congressman’s opening statement.
The appearance by Shkreli was the highlight of this congressional hearing, which explored the complicated reality of drug pricing in the US.
Bernie Sanders, a US presidential candidate, has long been protesting “skyrocketing drug prices” and has also proposed a new bill last year – The Prescription Drug Affordability Act of 2015.
FDA’s accelerated review plan
In this backdrop, the US Food and Drug Administration (FDA) announced a small regulatory change – it will prioritize review of new applications for generic drugs “that would compete with treatments made by only one company.”
The policy mentions that “potential first generic products for which there are no blocking patents or exclusivities on the reference listed drug may receive expedited review”.
In an email to Bloomberg, the FDA estimates the change in prioritization could expedite review of as many as 125 generic drug applications.
The next ‘price-gouging’ targets
PharmaCompass has found over 300 different dosage forms of drugs which currently have no patents and no competition.
Our compilation covers a broad range of products from Pfizer's Premarin, isolated from pregnant mares’ urine, which brings in over US $ 1 billion in sales to Emcure’s BICNU (carmustine or BICNU is an anti-cancer, chemotherapy drug).
While Emcure was banned from exporting products to the United States, due to compliance problems found in their manufacturing operations, BICNU was exempted since there was no other alternative available in the market.
While an estimated 13 million people in the United States have latent tuberculosis infection (LTBI), Sanofi’s Priftin (rifapentine), launched last year in a new packaging, still has no generic competition.
Our view
Our list provides tremendous opportunities for generic companies in the short-term. In many cases, to capitalize on the opportunities, generic drug companies will need to partner with API manufacturers as the lack of sustained, quality API supply is a major reason that there are no competitors on the market.
However, it is important for generic companies to remember that the FDA’s continued focus on accelerating review of these drugs will require companies to rely on strategies less opportunistic than price-gouging, to drive their future business growth.
Active Ingredient
|
Dosage Form
|
Trade Name
|
Dosage Strength
|
NDA (N) /ANDA (A)
|
Application Number
|
Approval Date
|
Application Holder
|
|---|---|---|---|---|---|---|---|
| ACETIC ACID, GLACIAL; ALUMINUM ACETATE | SOLUTION/DROPS;OTIC | ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE | 2%;0.79% | A | 40063 | 2/25/1994 | BAUSCH AND LOMB PHARMACEUTICALS INC |
| CORTICORELIN OVINE TRIFLUTATE | INJECTABLE;INJECTION | ACTHREL | EQ 0.1MG BASE/VIAL | N | 20162 | 5/23/1996 | FERRING PHARMACEUTICALS INC |
| PEGADEMASE BOVINE | INJECTABLE;INJECTION | ADAGEN | 250 UNITS/ML | N | 19818 | 3/21/1990 | SIGMA TAU PHARMACEUTICALS INC |
| ADAPALENE | SOLUTION;TOPICAL | ADAPALENE | 0.10% | A | 204593 | 1/5/2016 | CALL INC DBA ROCHESTER PHARMACEUTICALS |
| ERYTHROMYCIN | OINTMENT;TOPICAL | AKNE-MYCIN | 2% | N | 50584 | 1/10/1985 | DOW PHARMACEUTICAL SCIENCES |
| ALBENDAZOLE | TABLET;ORAL | ALBENZA | 200MG | N | 20666 | 6/11/1996 | AMEDRA PHARMACEUTICALS LLC |
| LODOXAMIDE TROMETHAMINE | SOLUTION/DROPS;OPHTHALMIC | ALOMIDE | EQ 0.1% BASE | N | 20191 | 9/23/1993 | ALCON LABORATORIES INC |
| ALPRAZOLAM | CONCENTRATE;ORAL | ALPRAZOLAM | 1MG/ML | A | 74312 | 10/31/1993 | ROXANE LABORATORIES INC |
| AMANTADINE HYDROCHLORIDE | TABLET;ORAL | AMANTADINE HYDROCHLORIDE | 100MG | A | 76186 | 12/16/2002 | USL PHARMA INC |
| AMCINONIDE | LOTION;TOPICAL | AMCINONIDE | 0.10% | A | 76329 | 11/6/2002 | FOUGERA PHARMACEUTICALS INC |
| AMMONIUM CHLORIDE | INJECTABLE;INJECTION | AMMONIUM CHLORIDE IN PLASTIC CONTAINER | 5MEQ/ML | A | 88366 | 6/13/1984 | HOSPIRA INC |
| AMPHOTERICIN B | INJECTABLE;INJECTION | AMPHOTERICIN B | 50MG/VIAL | A | 63206 | 4/29/1992 | X GEN PHARMACEUTICALS INC |
| INAMRINONE LACTATE | INJECTABLE;INJECTION | AMRINONE LACTATE | EQ 5MG BASE/ML | A | 75513 | 5/9/2000 | EUROHEALTH INTERNATIONAL SARL |
| OXYMETHOLONE | TABLET;ORAL | ANADROL-50 | 50MG | N | 16848 | 1/1/1982 | MEDA PHARMACEUTICALS INC |
| VITAMIN A PALMITATE | INJECTABLE;INJECTION | AQUASOL A | EQ 50,000 UNITS BASE/ML | N | 6823 | 1/1/1982 | HOSPIRA INC |
| DOXYCYCLINE HYCLATE | SYSTEM, EXTENDED RELEASE;PERIODONTAL | ATRIDOX | 50MG | N | 50751 | 9/3/1998 | TOLMAR INC |
| ATROPINE SULFATE | SOLUTION/DROPS;OPHTHALMIC | ATROPINE SULFATE | 1% | N | 206289 | 7/18/2014 | AKORN INC |
| AZATHIOPRINE SODIUM | INJECTABLE;INJECTION | AZATHIOPRINE SODIUM | EQ 100MG BASE/VIAL | A | 74419 | 3/31/1995 | EUROHEALTH INTERNATIONAL SARL |
| AZELAIC ACID | CREAM;TOPICAL | AZELEX | 20% | N | 20428 | 9/13/1995 | ALLERGAN INC |
| BRINZOLAMIDE | SUSPENSION/DROPS;OPHTHALMIC | AZOPT | 1% | N | 20816 | 4/1/1998 | ALCON PHARMACEUTICALS LTD |
| SULFASALAZINE | SUSPENSION;ORAL | AZULFIDINE | 250MG/5ML | A | 86983 | 1/1/1982 | PHARMACIA AND UPJOHN CO |
| BACITRACIN | OINTMENT;OPHTHALMIC | BACITRACIN | 500 UNITS/GM | A | 61212 | 1/1/1982 | PERRIGO CO TENNESSEE INC |
| MUPIROCIN CALCIUM | OINTMENT;NASAL | BACTROBAN | EQ 2% BASE | N | 50703 | 9/18/1995 | GLAXOSMITHKLINE |
| DIMERCAPROL | INJECTABLE;INJECTION | BAL | 10% | N | 5939 | 1/1/1982 | AKORN INC |
| BECLOMETHASONE DIPROPIONATE MONOHYDRATE | SPRAY, METERED;NASAL | BECONASE AQ | EQ 0.042MG DIPROP/SPRAY | N | 19389 | 7/27/1987 | GLAXOSMITHKLINE |
| POVIDONE-IODINE | SOLUTION/DROPS;OPHTHALMIC | BETADINE | 5% | N | 18634 | 12/17/1986 | ALCON PHARMACEUTICALS LTD |
| BETAXOLOL HYDROCHLORIDE | SUSPENSION/DROPS;OPHTHALMIC | BETOPTIC S | EQ 0.25% BASE | N | 19845 | 12/29/1989 | ALCON LABORATORIES INC |
| CARMUSTINE | INJECTABLE;INJECTION | BICNU | 100MG/VIAL | N | 17422 | 1/1/1982 | EMCURE PHARMACEUTICALS LTD |
| PRAZIQUANTEL | TABLET;ORAL | BILTRICIDE | 600MG | N | 18714 | 12/29/1982 | BAYER HEALTHCARE PHARMACEUTICALS INC |
| PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM | OINTMENT;OPHTHALMIC | BLEPHAMIDE S.O.P. | 0.2%;10% | A | 87748 | 12/3/1986 | ALLERGAN PHARMACEUTICAL |
| ACETAMINOPHEN; BUTALBITAL; CAFFEINE | SOLUTION;ORAL | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | 325MG/15ML;50MG/15ML;40MG/15ML | A | 40387 | 1/31/2003 | MIKART INC |
| CALCIPOTRIENE | OINTMENT;TOPICAL | CALCIPOTRIENE | 0.01% | A | 90633 | 3/24/2010 | GLENMARK GENERICS INC USA |
| CALCITRIOL | INJECTABLE;INJECTION | CALCITRIOL | 0.001MG/ML | A | 78066 | 1/29/2008 | AKORN INC |
| CALCIUM CHLORIDE | INJECTABLE;INJECTION | CALCIUM CHLORIDE 10% IN PLASTIC CONTAINER | 100MG/ML | N | 21117 | 1/28/2000 | HOSPIRA INC |
| EDETATE CALCIUM DISODIUM | INJECTABLE;INJECTION | CALCIUM DISODIUM VERSENATE | 200MG/ML | N | 8922 | 1/1/1982 | MEDICIS PHARMACEUTICAL CORP |
| CAPREOMYCIN SULFATE | INJECTABLE;INJECTION | CAPASTAT SULFATE | EQ 1GM BASE/VIAL | N | 50095 | 1/1/1982 | AKORN INC |
| FLUOCINOLONE ACETONIDE | SHAMPOO;TOPICAL | CAPEX | 0.01% | N | 20001 | 8/27/1990 | GALDERMA LABORATORIES LP |
| ACETAMINOPHEN; CODEINE PHOSPHATE | SUSPENSION;ORAL | CAPITAL AND CODEINE | 120MG/5ML;12MG/5ML | A | 86024 | 1/1/1982 | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| SUCRALFATE | SUSPENSION;ORAL | CARAFATE | 1GM/10ML | N | 19183 | 12/16/1993 | FOREST LABORATORIES INC |
| RUBIDIUM CHLORIDE RB-82 | INJECTABLE;INJECTION | CARDIOGEN-82 | N/A | N | 19414 | 12/29/1989 | BRACCO DIAGNOSTICS INC |
| ASPIRIN; CARISOPRODOL; CODEINE PHOSPHATE | TABLET;ORAL | CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE | 325MG;200MG;16MG | A | 40118 | 4/16/1996 | SANDOZ INC |
| CEFAZOLIN SODIUM | SOLUTION;INTRAVENOUS | CEFAZOLIN IN PLASTIC CONTAINER | EQ 2GM BASE/100ML (EQ 20MG BASE/ML) | N | 207131 | 8/7/2015 | BAXTER HEALTHCARE CORP |
| CEFOXITIN SODIUM | POWDER;IV (INFUSION) | CEFOXITIN IN PLASTIC CONTAINER | EQ 100GM BASE | A | 200938 | 11/16/2015 | SAMSON MEDICAL TECHNOLOGIES LLC |
| MYCOPHENOLATE MOFETIL HYDROCHLORIDE | INJECTABLE;INJECTION | CELLCEPT | 500MG/VIAL | N | 50758 | 8/12/1998 | ROCHE PALO ALTO LLC |
| TECHNETIUM TC-99M EXAMETAZIME KIT | INJECTABLE;INJECTION | CERETEC | N/A | N | 19829 | 12/30/1988 | GE HEALTHCARE |
| DINOPROSTONE | INSERT, EXTENDED RELEASE;VAGINAL | CERVIDIL | 10MG | N | 20411 | 3/30/1995 | FERRING PHARMACEUTICALS INC |
| NABILONE | CAPSULE;ORAL | CESAMET | 1MG | N | 18677 | 12/26/1985 | MEDA PHARMACEUTICALS INC |
| CIPROFLOXACIN HYDROCHLORIDE | SOLUTION/DROPS;OTIC | CETRAXAL | EQ 0.2% BASE | N | 21918 | 5/1/2009 | WRASER PHARMACEUTICALS LLC |
| CHENODIOL | TABLET;ORAL | CHENODIOL | 250MG | A | 91019 | 10/22/2009 | NEXGEN PHARMA INC |
| CHLORAMPHENICOL SODIUM SUCCINATE | INJECTABLE;INJECTION | CHLORAMPHENICOL SODIUM SUCCINATE | EQ 1GM BASE/VIAL | A | 62365 | 8/25/1982 | FRESENIUS KABI USA LLC |
| CHLORPROMAZINE HYDROCHLORIDE | INJECTABLE;INJECTION | CHLORPROMAZINE HYDROCHLORIDE | 25MG/ML | A | 83329 | 1/1/1982 | EUROHEALTH INTERNATIONAL SARL |
| CHROMIC CHLORIDE | INJECTABLE;INJECTION | CHROMIC CHLORIDE IN PLASTIC CONTAINER | EQ 0.004MG CHROMIUM/ML | N | 18961 | 6/26/1986 | HOSPIRA INC |
| CIPROFLOXACIN HYDROCHLORIDE | OINTMENT;OPHTHALMIC | CILOXAN | EQ 0.3% BASE | N | 20369 | 3/30/1998 | ALCON PHARMACEUTICALS LTD |
| CIMETIDINE HYDROCHLORIDE | INJECTABLE;INJECTION | CIMETIDINE HYDROCHLORIDE | EQ 300MG BASE/2ML | A | 74428 | 4/25/1996 | DAVA PHARMACEUTICALS INC |
| CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE | SUSPENSION/DROPS;OTIC | CIPRO HC | EQ 0.2% BASE;1% | N | 20805 | 2/10/1998 | ALCON PHARMACEUTICALS LTD |
| ESTRADIOL; LEVONORGESTREL | FILM, EXTENDED RELEASE;TRANSDERMAL | CLIMARA PRO | 0.045MG/24HR;0.015MG/24HR | N | 21258 | 11/21/2003 | BAYER HEALTHCARE PHARMACEUTICALS INC |
| CLOCORTOLONE PIVALATE | CREAM;TOPICAL | CLODERM | 0.10% | N | 17765 | 1/1/1982 | PROMIUS PHARMA LLC |
| COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE | SUSPENSION/DROPS;OTIC | COLY-MYCIN S | EQ 3MG BASE/ML; 10MG/ML;EQ 3.3MG BASE/ML; 0.5MG/ML | N | 50356 | 1/1/1982 | ENDO PHARMACEUTICALS INC |
| PODOFILOX | GEL;TOPICAL | CONDYLOX | 0.50% | N | 20529 | 3/13/1997 | ACTAVIS LABORATORIES UT INC |
| FLURANDRENOLIDE | LOTION;TOPICAL | CORDRAN | 0.05% | N | 13790 | 1/1/1982 | AQUA PHARMACEUTICALS |
| FLURANDRENOLIDE | OINTMENT;TOPICAL | CORDRAN | 0.05% | N | 12806 | 1/1/1982 | AQUA PHARMACEUTICALS |
| FLURANDRENOLIDE | TAPE;TOPICAL | CORDRAN | 0.004MG/SQ CM | N | 16455 | 1/1/1982 | ACTAVIS LABORATORIES UT INC |
| HYDROCORTISONE ACETATE | AEROSOL, METERED;RECTAL | CORTIFOAM | 10% | N | 17351 | 2/10/1982 | MEDA PHARMACEUTICALS INC |
| HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | CREAM;TOPICAL | CORTISPORIN | 0.5%;EQ 3.5MG BASE/GM; 10,000 UNITS/GM | N | 50218 | 8/9/1985 | MONARCH PHARMACEUTICALS INC |
| ETHINYL ESTRADIOL; NORGESTREL | TABLET;ORAL-21 | CRYSELLE | 0.03MG;0.3MG | A | 75840 | 11/30/2001 | DURAMED PHARMACEUTICALS INC SUB BARR LABORATORIES INC |
| CUPRIC CHLORIDE | INJECTABLE;INJECTION | CUPRIC CHLORIDE IN PLASTIC CONTAINER | EQ 0.4MG COPPER/ML | N | 18960 | 6/26/1986 | HOSPIRA INC |
| PENICILLAMINE | CAPSULE;ORAL | CUPRIMINE | 250MG | N | 19853 | 1/1/1982 | ATON PHARMA INC |
| PORACTANT ALFA | SUSPENSION;INTRATRACHEAL | CUROSURF | 80MG/ML | N | 20744 | 11/18/1999 | CHIESI USA INC |
| CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | CYCLOMYDRIL | 0.2%;1% | A | 84300 | 1/1/1982 | ALCON LABORATORIES INC |
| BETAINE HYDROCHLORIDE | FOR SOLUTION;ORAL | CYSTADANE | 1GM/SCOOPFUL | N | 20576 | 10/25/1996 | RARE DISEASE THERAPEUTICS INC |
| PYRIMETHAMINE | TABLET;ORAL | DARAPRIM | 25MG | N | 8578 | 1/1/1982 | TURING PHARMACEUTICALS AG |
| DECITABINE | POWDER;INTRAVENOUS | DECITABINE | 50MG/VIAL | N | 205582 | 1/28/2014 | SUN PHARMA GLOBAL FZE |
| METYROSINE | CAPSULE;ORAL | DEMSER | 250MG | N | 17871 | 1/1/1982 | ATON PHARMA DIV VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| PENICILLAMINE | TABLET;ORAL | DEPEN | 250MG | N | 19854 | 1/1/1982 | MEDA PHARMACEUTICALS INC |
| CYTARABINE | INJECTABLE, LIPOSOMAL;INJECTION | DEPOCYT | 10MG/ML | N | 21041 | 4/1/1999 | PACIRA PHARMACEUTICALS INC |
| DEXAMETHASONE | SOLUTION;ORAL | DEXAMETHASONE | 0.5MG/5ML | A | 88248 | 9/1/1983 | ROXANE LABORATORIES INC |
| DEXAMETHASONE | CONCENTRATE;ORAL | DEXAMETHASONE INTENSOL | 1MG/ML | A | 88252 | 9/1/1983 | ROXANE LABORATORIES INC |
| DEXCHLORPHENIRAMINE MALEATE | SYRUP;ORAL | DEXCHLORPHENIRAMINE MALEATE | 2MG/5ML | A | 88251 | 3/23/1984 | WOCKHARDT EU OPERATIONS (SWISS) AG |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM CHLORIDE; SODIUM LACTATE | INJECTABLE;INJECTION | DEXTROSE 5% AND ELECTROLYTE NO. 48 IN PLASTIC CONTAINER | 5GM/100ML; 31MG/100ML; 141MG/100ML; 20MG/100ML; 12MG/100ML; 260MG/100ML | N | 17484 | 1/1/1982 | BAXTER HEALTHCARE CORP |
| DIAZEPAM | SOLUTION;ORAL | DIAZEPAM | 5MG/5ML | A | 70928 | 4/3/1987 | ROXANE LABORATORIES INC |
| DICYCLOMINE HYDROCHLORIDE | SYRUP;ORAL | DICYCLOMINE HYDROCHLORIDE | 10MG/5ML | A | 40169 | 3/24/2005 | MIKART INC |
| DIGOXIN | ELIXIR;ORAL | DIGOXIN | 0.05MG/ML | N | 21648 | 8/26/2004 | ROXANE LABORATORIES INC |
| ISOSORBIDE DINITRATE | CAPSULE, EXTENDED RELEASE;ORAL | DILATRATE-SR | 40MG | N | 19790 | 9/2/1988 | AUXILIUM PHARMACEUTICALS LLC |
| DIMENHYDRINATE | INJECTABLE;INJECTION | DIMENHYDRINATE | 50MG/ML | A | 40519 | 6/23/2004 | FRESENIUS KABI USA LLC |
| OLSALAZINE SODIUM | CAPSULE;ORAL | DIPENTUM | 250MG | N | 19715 | 7/31/1990 | MEDA PHARMACEUTICALS INC |
| DIPHENHYDRAMINE HYDROCHLORIDE | CAPSULE;ORAL | DIPHENHYDRAMINE HYDROCHLORIDE | 50MG | A | 80738 | 1/1/1982 | BARR LABORATORIES INC |
| DIPHENHYDRAMINE HYDROCHLORIDE | ELIXIR;ORAL | DIPHENHYDRAMINE HYDROCHLORIDE | 12.5MG/5ML | A | 87513 | 2/10/1982 | PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS |
| ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE | SOLUTION;ORAL | DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE | 0.025MG/5ML;2.5MG/5ML | A | 87708 | 5/3/1982 | ROXANE LABORATORIES INC |
| CHLOROTHIAZIDE | SUSPENSION;ORAL | DIURIL | 250MG/5ML | N | 11870 | 1/1/1982 | SALIX PHARMACEUTICALS INC |
| METHADONE HYDROCHLORIDE | INJECTABLE;INJECTION | DOLOPHINE HYDROCHLORIDE | 10MG/ML | N | 21624 | 1/1/1982 | MYLAN INSTITUTIONAL LLC |
| ATROPINE; PRALIDOXIME CHLORIDE | INJECTABLE;INTRAMUSCULAR | DUODOTE | 2.1MG/0.7ML;600MG/2ML | N | 21983 | 9/28/2006 | MERIDIAN MEDICAL TECHNOLOGIES INC |
| ASPIRIN | CAPSULE, EXTENDED RELEASE;ORAL | DURLAZA | 162.5MG | N | 200671 | 9/4/2015 | NEW HAVEN PHARMACEUTICALS INC |
| ETHACRYNIC ACID | TABLET;ORAL | EDECRIN | 25MG | N | 16092 | 1/1/1982 | ATON PHARMA INC |
| THEOPHYLLINE | SOLUTION, ELIXIR;ORAL | ELIXOPHYLLIN | 80MG/15ML | A | 85186 | 1/1/1982 | NOSTRUM LABORATORIES INC |
| CALCIUM CHLORIDE; DEXTROSE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INJECTABLE;INTRATHECAL | ELLIOTTS B SOLUTION | 0.2MG/ML;0.8MG/ML; 0.3MG/ML;0.3MG/ML; 1.9MG/ML;7.3MG/ML; 0.2MG/ML | N | 20577 | 9/27/1996 | LUKARE MEDICAL LLC |
| PENTOSAN POLYSULFATE SODIUM | CAPSULE;ORAL | ELMIRON | 100MG | N | 20193 | 9/26/1996 | JANSSEN PHARMACEUTICALS INC |
| EMEDASTINE DIFUMARATE | SOLUTION/DROPS;OPHTHALMIC | EMADINE | 0.05% | N | 20706 | 12/29/1997 | ALCON LABORATORIES INC |
| ESTRAMUSTINE PHOSPHATE SODIUM | CAPSULE;ORAL | EMCYT | EQ 140MG PHOSPHATE | N | 18045 | 1/1/1982 | PHARMACIA AND UPJOHN CO |
| EDROPHONIUM CHLORIDE | INJECTABLE;INJECTION | ENLON | 10MG/ML | A | 88873 | 8/6/1985 | MYLAN INSTITUTIONAL LLC |
| ATROPINE SULFATE; EDROPHONIUM CHLORIDE | INJECTABLE;INJECTION | ENLON-PLUS | 0.14MG/ML;10MG/ML | N | 19678 | 11/6/1991 | MYLAN INSTITUTIONAL LLC |
| EPINEPHRINE HYDROCHLORIDE | SOLUTION;IV (INFUSION), INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS | EPINEPHRINE | EQ 1MG BASE/ML (EQ 1MG BASE/ML) | N | 205029 | 7/29/2014 | BELCHER PHARMACEUTICALS LLC |
| ERGOTAMINE TARTRATE | TABLET;SUBLINGUAL | ERGOMAR | 2MG | A | 87693 | 2/24/1983 | ROSEDALE THERAPEUTICS |
| SERTACONAZOLE NITRATE | CREAM;TOPICAL | ERTACZO | 2% | N | 21385 | 12/10/2003 | VALEANT PHARMACEUTICALS LUXEMBOURG SARL |
| ERYTHROMYCIN STEARATE | TABLET;ORAL | ERYTHROCIN STEARATE | EQ 250MG BASE | A | 60359 | 1/1/1982 | ARBOR PHARMACEUTICALS LLC |
| ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL | GRANULE;ORAL | ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL | EQ 200MG BASE/5ML; EQ 600MG BASE/5ML | A | 62759 | 5/20/1988 | BARR LABORATORIES INC |
| ESTRADIOL | CREAM;VAGINAL | ESTRACE | 0.01% | A | 86069 | 1/31/1984 | WARNER CHILCOTT US LLC |
| ESTRADIOL; NORGESTIMATE | TABLET;ORAL | ESTRADIOL AND NORGESTIMATE | 1MG,1MG;N/A,0.09MG | A | 76812 | 4/29/2005 | BARR LABORATORIES INC |
| ESTRADIOL HEMIHYDRATE | EMULSION;TOPICAL | ESTRASORB | 0.25% | N | 21371 | 10/9/2003 | MEDICIS PHARMACEUTICAL CORP |
| ESTRADIOL | INSERT, EXTENDED RELEASE;VAGINAL | ESTRING | 0.0075MG/24HR | N | 20472 | 4/26/1996 | PHARMACIA AND UPJOHN CO |
| ETHANOLAMINE OLEATE | INJECTABLE;INJECTION | ETHAMOLIN | 50MG/ML | N | 19357 | 12/22/1988 | QOL MEDICAL LLC |
| ETOPOSIDE PHOSPHATE | INJECTABLE;INJECTION | ETOPOPHOS PRESERVATIVE FREE | EQ 100MG BASE/VIAL | N | 20457 | 5/17/1996 | BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE |
| ETOPOSIDE | CAPSULE;ORAL | ETOPOSIDE | 50MG | A | 75635 | 9/19/2001 | MYLAN PHARMACEUTICALS INC |
| CROTAMITON | CREAM;TOPICAL | EURAX | 10% | N | 6927 | 1/1/1982 | RANBAXY LABORATORIES INC |
| SULCONAZOLE NITRATE | CREAM;TOPICAL | EXELDERM | 1% | N | 18737 | 2/28/1989 | RANBAXY LABORATORIES INC |
| SULCONAZOLE NITRATE | SOLUTION;TOPICAL | EXELDERM | 1% | N | 18738 | 8/30/1985 | RANBAXY LABORATORIES INC |
| BARIUM SULFATE | FOR SUSPENSION;ORAL | E-Z-HD | 334GM/BOTTLE | N | 208036 | 1/11/2016 | BRACCO DIAGNOSTICS INC |
| FAMOTIDINE | SUSPENSION;ORAL | FAMOTIDINE | 40MG/5ML | A | 201695 | 12/17/2012 | NOVEL LABORATORIES INC |
| TOREMIFENE CITRATE | TABLET;ORAL | FARESTON | EQ 60MG BASE | N | 20497 | 5/29/1997 | PROSTRAKAN INC |
| FENOPROFEN CALCIUM | TABLET;ORAL | FENOPROFEN CALCIUM | EQ 600MG BASE | A | 72267 | 8/17/1988 | MYLAN PHARMACEUTICALS INC |
| FLUOROMETHOLONE ACETATE | SUSPENSION/DROPS;OPHTHALMIC | FLAREX | 0.10% | N | 19079 | 2/11/1986 | ALCON LABORATORIES INC |
| FLUOXYMESTERONE | TABLET;ORAL | FLUOXYMESTERONE | 10MG | A | 88342 | 10/21/1983 | USL PHARMA INC |
| FLUPHENAZINE HYDROCHLORIDE | CONCENTRATE;ORAL | FLUPHENAZINE HYDROCHLORIDE | 5MG/ML | A | 74725 | 9/16/1996 | PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS |
| FLUPHENAZINE HYDROCHLORIDE | ELIXIR;ORAL | FLUPHENAZINE HYDROCHLORIDE | 2.5MG/5ML | A | 40146 | 8/21/1996 | PHARMACEUTICAL ASSOC INC DIV BEACH PRODUCTS |
| FLUPHENAZINE HYDROCHLORIDE | INJECTABLE;INJECTION | FLUPHENAZINE HYDROCHLORIDE | 2.5MG/ML | A | 89556 | 4/16/1987 | FRESENIUS KABI USA LLC |
| FLUOROMETHOLONE | OINTMENT;OPHTHALMIC | FML | 0.10% | N | 17760 | 9/4/1985 | ALLERGAN PHARMACEUTICAL |
| FOLIC ACID | INJECTABLE;INJECTION | FOLIC ACID | 5MG/ML | A | 89202 | 2/18/1986 | FRESENIUS KABI USA LLC |
| ENFUVIRTIDE | INJECTABLE;SUBCUTANEOUS | FUZEON | 90MG/VIAL | N | 21481 | 3/13/2003 | HOFFMANN LA ROCHE INC |
| CARMUSTINE | IMPLANT;INTRACRANIAL | GLIADEL | 7.7MG | N | 20637 | 9/23/1996 | ARBOR PHARMACEUTICALS LLC |
| IOTHALAMATE SODIUM I-125 | INJECTABLE;INJECTION | GLOFIL-125 | 250-300uCi/ML | N | 17279 | 1/1/1982 | ISOTEX DIAGNOSTICS |
| GLUCAGON HYDROCHLORIDE RECOMBINANT | INJECTABLE;INJECTION | GLUCAGEN | EQ 1MG BASE/VIAL | N | 20918 | 6/22/1998 | NOVO NORDISK PHARMACEUTICALS INC |
| GLUCAGON RECOMBINANT | INJECTABLE;INJECTION | GLUCAGON | 1MG/VIAL | N | 20928 | 9/11/1998 | ELI LILLY AND CO |
| GLUCAGON HYDROCHLORIDE | POWDER;INTRAMUSCULAR, INTRAVENOUS | GLUCAGON | EQ 1MG BASE/VIAL | N | 201849 | 5/8/2015 | FRESENIUS KABI USA LLC |
| GUANIDINE HYDROCHLORIDE | TABLET;ORAL | GUANIDINE HYDROCHLORIDE | 125MG | N | 1546 | 1/1/1982 | MERCK SHARP AND DOHME CORP |
| HALCINONIDE | CREAM;TOPICAL | HALOG | 0.10% | N | 17556 | 1/1/1982 | RANBAXY LABORATORIES INC |
| HALCINONIDE | OINTMENT;TOPICAL | HALOG | 0.10% | N | 17824 | 1/1/1982 | RANBAXY LABORATORIES INC |
| CARBOPROST TROMETHAMINE | INJECTABLE;INJECTION | HEMABATE | EQ 0.25MG BASE/ML | N | 17989 | 1/1/1982 | PHARMACIA AND UPJOHN CO |
| TECHNETIUM TC-99M DISOFENIN KIT | INJECTABLE;INJECTION | HEPATOLITE | N/A | N | 18467 | 3/16/1982 | PHARMALUCENCE INC |
| ALTRETAMINE | CAPSULE;ORAL | HEXALEN | 50MG | N | 19926 | 12/26/1990 | EISAI INC |
| GUAIFENESIN; HYDROCODONE BITARTRATE; PSEUDOEPHEDRINE HYDROCHLORIDE | SOLUTION;ORAL | HYCOFENIX | 200MG/5ML;2.5MG/5ML;30MG/5ML | N | 22279 | 5/14/2015 | MIKART INC |
| HYDROCORTISONE VALERATE | OINTMENT;TOPICAL | HYDROCORTISONE VALERATE | 0.20% | A | 75043 | 8/25/1998 | TARO PHARMACEUTICALS INC |
| HYDROXYPROGESTERONE CAPROATE | INJECTABLE;INJECTION | HYDROXYPROGESTERONE CAPROATE | 250MG/ML | A | 200271 | 8/24/2015 | ASPEN GLOBAL INC |
| CITRIC ACID; UREA C-13 | FOR SOLUTION, TABLET, FOR SOLUTION;ORAL | IDKIT:HP | N/A,4GM;75MG,N/A | N | 21314 | 12/17/2002 | EXALENZ BIOSCIENCE LTD |
| INDIUM IN-111 OXYQUINOLINE | INJECTABLE;INJECTION | INDIUM IN-111 OXYQUINOLINE | 1mCi/ML | N | 19044 | 12/24/1985 | GE HEALTHCARE |
| INDOMETHACIN | SUSPENSION;ORAL | INDOCIN | 25MG/5ML | N | 18332 | 10/10/1985 | IROKO PHARMACEUTICALS LLC |
| INDOMETHACIN | INJECTABLE;INJECTION | INDOMETHACIN | EQ 1MG BASE/VIAL | N | 22536 | 3/17/2010 | FRESENIUS KABI USA LLC |
| INDOMETHACIN | SUPPOSITORY;RECTAL | INDOMETHACIN | 50MG | A | 73314 | 8/31/1992 | G AND W LABORATORIES INC |
| CALFACTANT | SUSPENSION;INTRATRACHEAL | INFASURF PRESERVATIVE FREE | 35MG/ML | N | 20521 | 7/1/1998 | ONY INC |
| ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5\'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K | INJECTABLE;INJECTION | INFUVITE ADULT | 2 IU/ML;40MG/ML; 12MCG/ML;40 IU/ML;1MCG/ML; 3MG/ML;120MCG/ML; 8MG/ML;1.2MG/ML; 0.72MG/ML;1.2MG/ML; 660 IU/ML;0.03MG/ML | N | 21163 | 5/18/2000 | SANDOZ CANADA INC |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM CHLORIDE; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS | INJECTABLE;INJECTION | IONOSOL B AND DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 53MG/100ML; 100MG/100ML; 100MG/100ML; 180MG/100ML; 280MG/100ML; 16MG/100ML | N | 19515 | 5/8/1986 | HOSPIRA INC |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM LACTATE; SODIUM PHOSPHATE, MONOBASIC ANHYDROUS | INJECTABLE;INJECTION | IONOSOL MB AND DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 30MG/100ML; 141MG/100ML; 15MG/100ML; 260MG/100ML; 25MG/100ML | N | 19513 | 5/8/1986 | HOSPIRA INC |
| DESIRUDIN RECOMBINANT | INJECTABLE;SUBCUTANEOUS | IPRIVASK | 15MG/VIAL | N | 21271 | 4/4/2003 | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | ISOLYTE H IN DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 30MG/100ML; 97MG/100ML; 220MG/100ML; 140MG/100ML | N | 19844 | 6/10/1993 | B BRAUN MEDICAL INC |
| DEXTROSE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | ISOLYTE M IN DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 150MG/100ML; 130MG/100ML; 280MG/100ML; 91MG/100ML | N | 19870 | 6/10/1993 | B BRAUN MEDICAL INC |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE | INJECTABLE;INJECTION | ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 31MG/100ML; 130MG/100ML; 26MG/100ML; 320MG/100ML | N | 19873 | 6/10/1993 | B BRAUN MEDICAL INC |
| MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; POTASSIUM PHOSPHATE, MONOBASIC; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE; SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | INJECTABLE;INJECTION | ISOLYTE S PH 7.4 IN PLASTIC CONTAINER | 30MG/100ML;37MG/100ML; 0.82MG/100ML; 370MG/100ML; 530MG/100ML; 500MG/100ML;12MG/100ML | N | 19696 | 9/29/1989 | B BRAUN MEDICAL INC |
| ISONIAZID | INJECTABLE;INJECTION | ISONIAZID | 100MG/ML | A | 40648 | 7/5/2005 | SANDOZ CANADA INC |
| ISONIAZID | SYRUP;ORAL | ISONIAZID | 50MG/5ML | A | 88235 | 11/10/1983 | CAROLINA MEDICAL PRODUCTS CO |
| ISOPROTERENOL HYDROCHLORIDE | INJECTABLE;INJECTION | ISUPREL | 0.2MG/ML | N | 10515 | 1/1/1982 | HOSPIRA INC |
| HYDROXYPROPYL CELLULOSE | INSERT;OPHTHALMIC | LACRISERT | 5MG | N | 18771 | 1/1/1982 | ATON PHARMA INC |
| LEVORPHANOL TARTRATE | TABLET;ORAL | LEVORPHANOL TARTRATE | 2MG | A | 74278 | 3/31/2000 | SENTYNL THERAPEUTICS INC |
| LIDOCAINE HYDROCHLORIDE | INJECTABLE;SPINAL | LIDOCAINE HYDROCHLORIDE 5% AND DEXTROSE 7.5% | 5% | A | 83914 | 1/1/1982 | HOSPIRA INC |
| ACETOHYDROXAMIC ACID | TABLET;ORAL | LITHOSTAT | 250MG | N | 18749 | 5/31/1983 | MISSION PHARMACAL CO |
| LOTEPREDNOL ETABONATE | OINTMENT;OPHTHALMIC | LOTEMAX | 0.50% | N | 200738 | 4/15/2011 | BAUSCH AND LOMB INC |
| MITOTANE | TABLET;ORAL | LYSODREN | 500MG | N | 16885 | 1/1/1982 | BRISTOL MYERS SQUIBB |
| ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5\'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E | FOR SOLUTION;IV (INFUSION) | M.V.I. PEDIATRIC | 80MG/VIAL;0.02MG/VIAL; 0.001MG/VIAL; 5MG/VIAL;0.01MG/VIAL 0.14MG/VIAL;17MG/VIAL; 0.2MG/VIAL;1MG/VIAL; 1.4MG/VIAL; EQ 1.2MG BASE/VIAL; 0.7MG/VIAL;7MG/VIAL | N | 18920 | 9/21/2000 | HOSPIRA INC |
| MANGANESE CHLORIDE | INJECTABLE;INJECTION | MANGANESE CHLORIDE IN PLASTIC CONTAINER | EQ 0.1MG MANGANESE/ML | N | 18962 | 6/26/1986 | HOSPIRA INC |
| ISOCARBOXAZID | TABLET;ORAL | MARPLAN | 10MG | N | 11961 | 1/1/1982 | VALIDUS PHARMACEUTICALS INC |
| PROCARBAZINE HYDROCHLORIDE | CAPSULE;ORAL | MATULANE | EQ 50MG BASE | N | 16785 | 1/1/1982 | SIGMA TAU PHARMACEUTICALS INC |
| DEXAMETHASONE | SUSPENSION/DROPS;OPHTHALMIC | MAXIDEX | 0.10% | N | 13422 | 1/1/1982 | ALCON LABORATORIES INC |
| MEBENDAZOLE | TABLET, CHEWABLE;ORAL | MEBENDAZOLE | 100MG | A | 73580 | 1/4/1995 | AMEDRA PHARMACEUTICALS LLC |
| MECAMYLAMINE HYDROCHLORIDE | TABLET;ORAL | MECAMYLAMINE HYDROCHLORIDE | 2.5MG | A | 204054 | 3/19/2013 | NEXGEN PHARMA INC |
| MEPERIDINE HYDROCHLORIDE | SYRUP;ORAL | MEPERIDINE HYDROCHLORIDE | 50MG/5ML | A | 88744 | 1/30/1985 | ROXANE LABORATORIES INC |
| MESNA | TABLET;ORAL | MESNEX | 400MG | N | 20855 | 3/21/2002 | BAXTER HEALTHCARE CORP |
| PYRIDOSTIGMINE BROMIDE | SYRUP;ORAL | MESTINON | 60MG/5ML | N | 15193 | 1/1/1982 | VALEANT PHARMACEUTICALS NORTH AMERICA LLC |
| METAPROTERENOL SULFATE | SYRUP;ORAL | METAPROTERENOL SULFATE | 10MG/5ML | A | 73632 | 7/22/1992 | SILARX PHARMACEUTICALS INC |
| METARAMINOL BITARTRATE | INJECTABLE;INJECTION | METARAMINOL BITARTRATE | EQ 10MG BASE/ML | A | 80722 | 1/1/1982 | FRESENIUS KABI USA LLC |
| ASPIRIN; METHOCARBAMOL | TABLET;ORAL | METHOCARBAMOL AND ASPIRIN | 325MG;400MG | A | 81145 | 1/31/1995 | JEROME STEVENS PHARMACEUTICALS INC |
| METHYCLOTHIAZIDE | TABLET;ORAL | METHYCLOTHIAZIDE | 5MG | A | 87672 | 8/17/1982 | MYLAN PHARMACEUTICALS INC |
| METHYLDOPATE HYDROCHLORIDE | INJECTABLE;INJECTION | METHYLDOPATE HYDROCHLORIDE | 50MG/ML | A | 71279 | 10/2/1987 | LUITPOLD PHARMACEUTICALS INC |
| METHYLERGONOVINE MALEATE | TABLET;ORAL | METHYLERGONOVINE MALEATE | 0.2MG | A | 91577 | 5/2/2011 | NOVEL LABORATORIES INC |
| CAFFEINE; ERGOTAMINE TARTRATE | SUPPOSITORY;RECTAL | MIGERGOT | 100MG;2MG | A | 86557 | 10/4/1983 | HORIZON PHARMA RHEUMATOLOGY LLC |
| DIHYDROERGOTAMINE MESYLATE | SPRAY, METERED;NASAL | MIGRANAL | 0.5MG/INH | N | 20148 | 12/8/1997 | VALEANT PHARMACEUTICALS INTERNATIONAL |
| ACETYLCHOLINE CHLORIDE | FOR SOLUTION;OPHTHALMIC | MIOCHOL-E | 20MG/VIAL | N | 20213 | 9/22/1993 | BAUSCH AND LOMB INC |
| CARBACHOL | SOLUTION;INTRAOCULAR | MIOSTAT | 0.01% | N | 16968 | 1/1/1982 | ALCON LABORATORIES INC |
| FOSFOMYCIN TROMETHAMINE | FOR SUSPENSION;ORAL | MONUROL | EQ 3GM BASE/PACKET | N | 50717 | 12/19/1996 | ZAMBON SPA ITALY |
| TECHNETIUM TC-99M SUCCIMER KIT | INJECTABLE;INJECTION | MPI DMSA KIDNEY REAGENT | N/A | N | 17944 | 5/18/1982 | GE HEALTHCARE |
| INDIUM IN-111 PENTETATE DISODIUM | INJECTABLE;INTRATHECAL | MPI INDIUM DTPA IN 111 | 1mCi/ML | N | 17707 | 2/18/1982 | GE HEALTHCARE |
| MECHLORETHAMINE HYDROCHLORIDE | INJECTABLE;INJECTION | MUSTARGEN | 10MG/VIAL | N | 6695 | 1/1/1982 | RECORDATI RARE DISEASES INC |
| BUSULFAN | TABLET;ORAL | MYLERAN | 2MG | N | 9386 | 1/1/1982 | ASPEN GLOBAL INC |
| NANDROLONE DECANOATE | INJECTABLE;INJECTION | NANDROLONE DECANOATE | 200MG/ML | A | 91252 | 8/30/2010 | PHARMAFORCE INC |
| NAPHAZOLINE HYDROCHLORIDE | SOLUTION/DROPS;OPHTHALMIC | NAPHAZOLINE HYDROCHLORIDE | 0.10% | A | 83590 | 1/1/1982 | AKORN INC |
| NATAMYCIN | SUSPENSION;OPHTHALMIC | NATACYN | 5% | N | 50514 | 1/1/1982 | ALCON LABORATORIES INC |
| NESIRITIDE RECOMBINANT | FOR SOLUTION;INTRAVENOUS | NATRECOR | 1.5MG/VIAL | N | 20920 | 8/10/2001 | SCIOS LLC |
| PENTAMIDINE ISETHIONATE | FOR SOLUTION;INHALATION | NEBUPENT | 300MG/VIAL | N | 19887 | 6/15/1989 | FRESENIUS KABI USA LLC |
| PENTOBARBITAL SODIUM | INJECTABLE;INJECTION | NEMBUTAL SODIUM | 50MG/ML | A | 83246 | 1/1/1982 | OAK PHARMACEUTICALS INC |
| NEOMYCIN SULFATE | SOLUTION;ORAL | NEO-FRADIN | EQ 87.5MG BASE/5ML | A | 65010 | 5/23/2002 | X GEN PHARMACEUTICALS INC |
| HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE | SUSPENSION/DROPS;OPHTHALMIC | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | 1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML | A | 62874 | 5/11/1988 | ALCON PHARMACEUTICALS LTD |
| FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE | CREAM;TOPICAL | NEO-SYNALAR | 0.025%;EQ 3.5MG BASE/GM | A | 60700 | 1/1/1982 | MEDIMETRIKS PHARMACEUTICALS INC |
| TECHNETIUM TC-99M BICISATE KIT | INJECTABLE;INJECTION | NEUROLITE | N/A | N | 20256 | 11/23/1994 | LANTHEUS MEDICAL IMAGING INC |
| NICOTINE | INHALANT;ORAL | NICOTROL | 4MG/CARTRIDGE | N | 20714 | 5/2/1997 | PHARMACIA AND UPJOHN CO |
| NICOTINE | SPRAY, METERED;NASAL | NICOTROL | 0.5MG/SPRAY | N | 20385 | 3/22/1996 | PFIZER INC |
| NITROGLYCERIN | OINTMENT;TRANSDERMAL | NITROGLYCERIN | 2% | A | 87355 | 7/8/1988 | E FOUGERA DIV ALTANA INC |
| SODIUM NITROPRUSSIDE | INJECTABLE;INJECTION | NITROPRESS | 25MG/ML | A | 71961 | 8/1/1988 | HOSPIRA WORLDWIDE, INC |
| NIZATIDINE | SOLUTION;ORAL | NIZATIDINE | 15MG/ML | A | 90576 | 11/18/2009 | AMNEAL PHARMACEUTICALS |
| ETHINYL ESTRADIOL; NORGESTIMATE | TABLET;ORAL | NORGESTIMATE AND ETHINYL ESTRADIOL | 0.035MG,0.035MG, 0.035MG;0.18MG, 0.215MG,0.25MG | A | 200494 | 6/17/2011 | GLENMARK GENERICS LTD |
| MESTRANOL; NORETHINDRONE | TABLET;ORAL-28 | NORINYL 1+50 28-DAY | 0.05MG;1MG | N | 16659 | 1/1/1982 | ACTAVIS LABORATORIES UT INC |
| DEXTROSE; MAGNESIUM ACETATE; POTASSIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | NORMOSOL-M AND DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 21MG/100ML; 128MG/100ML; 234MG/100ML | N | 17610 | 1/1/1982 | HOSPIRA INC |
| DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE | INJECTABLE;INJECTION | NORMOSOL-R AND DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 30MG/100ML; 37MG/100ML; 222MG/100ML; 526MG/100ML; 502MG/100ML | N | 17609 | 1/1/1982 | HOSPIRA INC |
| GLUTAMINE | FOR SOLUTION;ORAL | NUTRESTORE | 5GM/PACKET | N | 21667 | 6/10/2004 | EMMAUS MEDICAL INC |
| NYSTATIN | TABLET;VAGINAL | NYSTATIN | 100,000 UNITS | A | 62615 | 10/17/1985 | ODYSSEY PHARMACEUTICALS INC |
| AMOXICILLIN; CLARITHROMYCIN; OMEPRAZOLE | CAPSULE, TABLET, CAPSULE, DELAYED RELEASE;ORAL | OMEPRAZOLE AND CLARITHROMYCIN AND AMOXICILLIN | 500MG,N/A,N/A; N/A,500MG,N/A; N/A,N/A,20MG | N | 50824 | 2/8/2011 | GASTROENTERO LOGIC LLC |
| IOHEXOL | FOR SOLUTION;ORAL | ORALTAG | 9.7GM/BOT | N | 205383 | 3/26/2015 | INTERPHARMA PRAHA AS |
| OXICONAZOLE NITRATE | LOTION;TOPICAL | OXISTAT | EQ 1% BASE | N | 20209 | 9/30/1992 | FOUGERA PHARMACEUTICALS INC |
| HYDROCORTISONE PROBUTATE | CREAM;TOPICAL | PANDEL | 0.10% | N | 20453 | 2/28/1997 | FOUGERA PHARMACEUTICALS INC |
| COPPER | INTRAUTERINE DEVICE;INTRAUTERINE | PARAGARD T 380A | 309MG/COPPER | N | 18680 | 11/15/1984 | TEVA WOMENS HEALTH INC |
| HYDROXYAMPHETAMINE HYDROBROMIDE; TROPICAMIDE | SOLUTION/DROPS;OPHTHALMIC | PAREMYD | 1%;0.25% | N | 19261 | 1/30/1992 | AKORN INC |
| AMINOSALICYLIC ACID | GRANULE, DELAYED RELEASE;ORAL | PASER | 4GM/PACKET | A | 74346 | 6/30/1994 | JACOBUS PHARMACEUTICAL CO |
| BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE | FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL | PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL | 5MG,N/A;N/A,210GM; N/A,0.74GM; N/A,2.86GM; N/A,5.6GM | A | 202217 | 8/20/2014 | NOVEL LABORATORIES INC |
| ETHOTOIN | TABLET;ORAL | PEGANONE | 250MG | N | 10841 | 1/1/1982 | RECORDATI RARE DISEASES INC |
| PENICILLIN G SODIUM | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | PENICILLIN G SODIUM | 5,000,000 UNITS/VIAL | A | 65068 | 2/26/2001 | SANDOZ INC |
| PENTAMIDINE ISETHIONATE | INJECTABLE;INJECTION | PENTAM | 300MG/VIAL | N | 19264 | 10/16/1984 | FRESENIUS KABI USA LLC |
| CHLORHEXIDINE GLUCONATE | TABLET;DENTAL | PERIOCHIP | 2.5MG | N | 20774 | 5/15/1998 | DEXCEL PHARMA TECHNOLOGIES LTD |
| PHENDIMETRAZINE TARTRATE | CAPSULE, EXTENDED RELEASE;ORAL | PHENDIMETRAZINE TARTRATE | 105MG | N | 18074 | 1/1/1982 | SANDOZ INC |
| HEXACHLOROPHENE | EMULSION;TOPICAL | PHISOHEX | 3% | N | 6882 | 1/1/1982 | SANOFI AVENTIS US LLC |
| ECHOTHIOPHATE IODIDE | FOR SOLUTION;OPHTHALMIC | PHOSPHOLINE IODIDE | 0.13% | N | 11963 | 1/1/1982 | WYETH PHARMACEUTICALS INC |
| PORFIMER SODIUM | INJECTABLE;INJECTION | PHOTOFRIN | 75MG/VIAL | N | 20451 | 12/27/1995 | CONCORDIA LABORATORIES INC |
| PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;IV (INFUSION) | PIPERACILLIN AND TAZOBACTAM | EQ 12GM BASE/VIAL;EQ 1.5GM BASE/VIAL | A | 203557 | 10/29/2014 | SANDOZ INC |
| DEXTROSE; MAGNESIUM ACETATE TETRAHYDRATE; POTASSIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | PLASMA-LYTE 56 AND DEXTROSE 5% IN PLASTIC CONTAINER | 5GM/100ML; 32MG/100ML; 128MG/100ML; 234MG/100ML | N | 17385 | 1/1/1982 | BAXTER HEALTHCARE CORP |
| POTASSIUM CHLORIDE | FOR SOLUTION;ORAL | POTASSIUM CHLORIDE | 20MEQ | N | 208019 | 8/19/2015 | PHARMA RESEARCH SOFTWARE SOLUTION LLC |
| GENTAMICIN SULFATE; PREDNISOLONE ACETATE | OINTMENT;OPHTHALMIC | PRED-G | EQ 0.3% BASE;0.6% | N | 50612 | 12/1/1989 | ALLERGAN PHARMACEUTICAL |
| GENTAMICIN SULFATE; PREDNISOLONE ACETATE | SUSPENSION/DROPS;OPHTHALMIC | PRED-G | EQ 0.3% BASE;1% | N | 50586 | 6/10/1988 | ALLERGAN PHARMACEUTICAL |
| PREDNISOLONE | TABLET;ORAL | PREDNISOLONE | 5MG | A | 80354 | 1/1/1982 | WATSON LABORATORIES INC |
| PREDNISOLONE SODIUM PHOSPHATE | SOLUTION/DROPS;OPHTHALMIC | PREDNISOLONE SODIUM PHOSPHATE | EQ 0.9% PHOSPHATE | A | 40070 | 7/29/1994 | BAUSCH AND LOMB PHARMACEUTICALS INC |
| ESTROGENS, CONJUGATED | CREAM;TOPICAL, VAGINAL | PREMARIN | 0.625MG/GM | N | 20216 | 1/1/1982 | WYETH PHARMACEUTICALS INC |
| ESTROGENS, CONJUGATED | INJECTABLE;INJECTION | PREMARIN | 25MG/VIAL | N | 10402 | 1/1/1982 | WYETH PHARMACEUTICALS INC |
| BENZYLPENICILLOYL POLYLYSINE | INJECTABLE;INJECTION | PRE-PEN | 60UMOLAR | N | 50114 | 1/1/1982 | ALLERQUEST LLC |
| DINOPROSTONE | GEL;ENDOCERVICAL | PREPIDIL | 0.5MG/3GM | N | 19617 | 12/9/1992 | PHARMACIA AND UPJOHN CO |
| RIFAPENTINE | TABLET;ORAL | PRIFTIN | 150MG | N | 21024 | 6/22/1998 | SANOFI AVENTIS US LLC |
| PRILOCAINE HYDROCHLORIDE | INJECTABLE;INJECTION | PRILOCAINE HYDROCHLORIDE | 4% | A | 79235 | 9/29/2010 | SEPTODONT INC |
| CILASTATIN SODIUM; IMIPENEM | POWDER;INTRAMUSCULAR | PRIMAXIN | EQ 500MG BASE/VIAL;500MG/VIAL | N | 50630 | 12/14/1990 | MERCK AND CO INC |
| AMINO ACIDS; CALCIUM ACETATE; GLYCERIN; MAGNESIUM ACETATE; PHOSPHORIC ACID; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | PROCALAMINE | 3%;26MG/100ML;3GM/100ML; 54MG/100ML;41MG/100ML; 150MG/100ML;200MG/100ML; 120MG/100ML | N | 18582 | 5/8/1982 | B BRAUN MEDICAL INC |
| DIAZOXIDE | SUSPENSION;ORAL | PROGLYCEM | 50MG/ML | N | 17453 | 1/1/1982 | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC |
| TACROLIMUS | INJECTABLE;INJECTION | PROGRAF | EQ 5MG BASE/ML | N | 50709 | 4/8/1994 | ASTELLAS PHARMA US INC |
| DINOPROSTONE | SUPPOSITORY;VAGINAL | PROSTIN E2 | 20MG | N | 17810 | 1/1/1982 | PHARMACIA AND UPJOHN CO |
| PROTAMINE SULFATE | INJECTABLE;INJECTION | PROTAMINE SULFATE | 10MG/ML | A | 89454 | 4/7/1987 | FRESENIUS KABI USA LLC |
| METHACHOLINE CHLORIDE | FOR SOLUTION;INHALATION | PROVOCHOLINE | 100MG/VIAL | N | 19193 | 10/31/1986 | METHAPHARM INC |
| PYRIDOXINE HYDROCHLORIDE | INJECTABLE;INJECTION | PYRIDOXINE HYDROCHLORIDE | 100MG/ML | A | 80618 | 1/1/1982 | FRESENIUS KABI USA LLC |
| SAMARIUM SM-153 LEXIDRONAM PENTASODIUM | INJECTABLE;INJECTION | QUADRAMET | 50mCi/ML | N | 20570 | 3/28/1997 | LANTHEUS MEDICAL IMAGING INC |
| QUINIDINE GLUCONATE | TABLET, EXTENDED RELEASE;ORAL | QUINIDINE GLUCONATE | 324MG | A | 89338 | 2/11/1987 | MUTUAL PHARMACEUTICAL CO INC |
| QUINIDINE SULFATE | TABLET, EXTENDED RELEASE;ORAL | QUINIDINE SULFATE | 300MG | A | 40045 | 6/30/1994 | G AND W LABORATORIES INC |
| FERRIC HEXACYANOFERRATE(II) | CAPSULE;ORAL | RADIOGARDASE (PRUSSIAN BLUE) | 500MG | N | 21626 | 10/2/2003 | HEYL CHEMISCH PHARMAZEUTISHE FABRIK |
| NITROGLYCERIN | OINTMENT;INTRA-ANAL | RECTIV | 0.40% | N | 21359 | 6/21/2011 | FOREST LABORATORIES INC |
| ZANAMIVIR | POWDER;INHALATION | RELENZA | 5MG | N | 21036 | 7/26/1999 | GLAXOSMITHKLINE |
| CITRIC ACID; GLUCONOLACTONE; MAGNESIUM CARBONATE | SOLUTION;IRRIGATION | RENACIDIN | 6.602GM/100ML; 198MG/100ML; 3.177GM/100ML | N | 19481 | 10/2/1990 | UNITED GUARDIAN INC |
| TRETINOIN | SOLUTION;TOPICAL | RETIN-A | 0.05% | N | 16921 | 1/1/1982 | VALEANT INTERNATIONAL BARBADOS SRL |
| ARGININE HYDROCHLORIDE | INJECTABLE;INJECTION | R-GENE 10 | 10GM/100ML | N | 16931 | 1/1/1982 | PHARMACIA AND UPJOHN CO |
| AURANOFIN | CAPSULE;ORAL | RIDAURA | 3MG | N | 18689 | 5/24/1985 | SEBELA IRELAND LTD |
| ISONIAZID; RIFAMPIN | CAPSULE;ORAL | RIFAMATE | 150MG;300MG | A | 61884 | 1/1/1982 | SANOFI AVENTIS US LLC |
| ISONIAZID; PYRAZINAMIDE; RIFAMPIN | TABLET;ORAL | RIFATER | 50MG;300MG;120MG | N | 50705 | 5/31/1994 | SANOFI AVENTIS US LLC |
| HYDROFLUMETHIAZIDE | TABLET;ORAL | SALURON | 50MG | N | 11949 | 1/1/1982 | SHIRE DEVELOPMENT LLC |
| LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | SCANDONEST L | 0.05MG/ML;2% | A | 88388 | 10/10/1984 | DEPROCO INC |
| TALC | AEROSOL, METERED;INTRAPLEURAL | SCLEROSOL | 400MG/SPRAY | N | 20587 | 12/24/1997 | BRYAN CORP |
| ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE | CAPSULE;ORAL | SEMPREX-D | 8MG;60MG | N | 19806 | 3/25/1994 | AUXILIUM PHARMACEUTICALS LLC |
| BETAMETHASONE DIPROPIONATE | SPRAY;TOPICAL | SERNIVO | EQ 0.05% BASE/SPRAY | N | 208079 | 2/5/2016 | PROMIUS PHARMA LLC |
| CYCLOSERINE | CAPSULE;ORAL | SEROMYCIN | 250MG | A | 60593 | 1/1/1982 | PURDUE GMP CENTER LLC DBA THE CHAO CENTER INDUSTRIAL PHARMACY |
| SODIUM ACETATE ANHYDROUS | INJECTABLE;INJECTION | SODIUM ACETATE IN PLASTIC CONTAINER | 2MEQ/ML | N | 18893 | 5/4/1983 | HOSPIRA INC |
| SODIUM LACTATE | INJECTABLE;INJECTION | SODIUM LACTATE IN PLASTIC CONTAINER | 5MEQ/ML | N | 18947 | 9/5/1984 | HOSPIRA INC |
| SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | INJECTABLE;INJECTION | SODIUM PHOSPHATES IN PLASTIC CONTAINER | 142MG/ML;276MG/ML | N | 18892 | 5/10/1983 | HOSPIRA INC |
| MANNITOL; SORBITOL | SOLUTION;IRRIGATION | SORBITOL-MANNITOL IN PLASTIC CONTAINER | 540MG/100ML;2.7GM/100ML | N | 18316 | 1/1/1982 | HOSPIRA INC |
| SOTALOL HYDROCHLORIDE | SOLUTION;ORAL | SOTYLIZE | 5MG/ML (5MG/ML) | N | 205108 | 10/22/2014 | ARBOR PHARMACEUTICALS LLC |
| STREPTOMYCIN SULFATE | INJECTABLE;INJECTION | STREPTOMYCIN SULFATE | EQ 1GM BASE/VIAL | A | 64210 | 6/30/1998 | X GEN PHARMACEUTICALS INC |
| SACROSIDASE | SOLUTION;ORAL | SUCRAID | 8,500 IU/ML | N | 20772 | 4/9/1998 | QOL MEDICAL LLC |
| SULFACETAMIDE SODIUM | OINTMENT;OPHTHALMIC | SULFACETAMIDE SODIUM | 10% | A | 80029 | 1/1/1982 | PERRIGO CO TENNESSEE INC |
| SULFADIAZINE | TABLET;ORAL | SULFADIAZINE | 500MG | A | 40091 | 7/29/1994 | SANDOZ INC |
| SULFAMETHOXAZOLE; TRIMETHOPRIM | INJECTABLE;INJECTION | SULFAMETHOXAZOLE AND TRIMETHOPRIM | 80MG/ML;16MG/ML | A | 73303 | 10/31/1991 | TEVA PHARMACEUTICALS USA |
| MAFENIDE ACETATE | CREAM;TOPICAL | SULFAMYLON | EQ 85MG BASE/GM | N | 16763 | 1/1/1982 | MYLAN INSTITUTIONAL INC |
| DESFLURANE | LIQUID;INHALATION | SUPRANE | 99.90% | N | 20118 | 9/18/1992 | BAXTER HEALTHCARE CORP |
| CEFIXIME | CAPSULE;ORAL | SUPRAX | 400MG | N | 203195 | 6/1/2012 | LUPIN LTD |
| CEFIXIME | TABLET;ORAL | SUPRAX | 400MG | A | 65130 | 2/12/2004 | LUPIN PHARMACEUTICALS INC |
| BERACTANT | SUSPENSION;INTRATRACHEAL | SURVANTA | 25MG/ML | N | 20032 | 7/1/1991 | ABBVIE INC |
| NAFARELIN ACETATE | SPRAY, METERED;NASAL | SYNAREL | EQ 0.2MG BASE/SPRAY | N | 19886 | 2/13/1990 | GD SEARLE LLC |
| DALFOPRISTIN; QUINUPRISTIN | INJECTABLE;IV (INFUSION) | SYNERCID | 350MG/VIAL;150MG/VIAL | N | 50748 | 9/21/1999 | KING PHARMACEUTICALS INC |
| TRIENTINE HYDROCHLORIDE | CAPSULE;ORAL | SYPRINE | 250MG | N | 19194 | 11/8/1985 | ATON PHARMA INC |
| TALC | POWDER;INTRAPLEURAL | TALC | 5GM/BOT | N | 21388 | 12/15/2003 | BRYAN CORP |
| PENTAZOCINE LACTATE | INJECTABLE;INJECTION | TALWIN | EQ 30MG BASE/ML | N | 16194 | 1/1/1982 | HOSPIRA INC |
| TECHNETIUM TC-99M OXIDRONATE KIT | INJECTABLE;INJECTION | TECHNESCAN | N/A | N | 18321 | 1/1/1982 | MALLINCKRODT NUCLEAR MEDICINE LLC |
| TECHNETIUM TC-99M MERTIATIDE KIT | INJECTABLE;INJECTION | TECHNESCAN MAG3 | N/A | N | 19882 | 6/15/1990 | MALLINCKRODT NUCLEAR MEDICINE LLC |
| OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE | OINTMENT;OPHTHALMIC | TERRAMYCIN W/ POLYMYXIN B SULFATE | EQ 5MG BASE/GM;10,000 UNITS/GM | A | 61015 | 1/1/1982 | PFIZER LABORATORIES DIV PFIZER INC |
| TESTOSTERONE | PELLET;IMPLANTATION | TESTOPEL | 75MG | A | 80911 | 1/1/1982 | ACTIENT PHARMACEUTICALS LLC |
| TETRACAINE HYDROCHLORIDE | SOLUTION;OPHTHALMIC | TETRACAINE HYDROCHLORIDE | 0.50% | N | 208135 | 2/29/2016 | ALCON RESEARCH LTD |
| HYDROCORTISONE | SOLUTION;TOPICAL | TEXACORT | 2.50% | A | 81271 | 4/17/1992 | MISSION PHARMACAL CO |
| THIOGUANINE | TABLET;ORAL | THIOGUANINE | 40MG | N | 12429 | 1/1/1982 | ASPEN GLOBAL INC |
| TIOPRONIN | TABLET;ORAL | THIOLA | 100MG | N | 19569 | 8/11/1988 | MISSION PHARMACAL CO |
| THIOTEPA | INJECTABLE;INJECTION | THIOTEPA | 15MG/VIAL | A | 75547 | 4/2/2001 | EUROHEALTH INTERNATIONAL SARL |
| DEXAMETHASONE; TOBRAMYCIN | OINTMENT;OPHTHALMIC | TOBRADEX | 0.1%;0.3% | N | 50616 | 9/28/1988 | ALCON LABORATORIES INC |
| TOBRAMYCIN | OINTMENT;OPHTHALMIC | TOBREX | 0.30% | N | 50555 | 1/1/1982 | ALCON LABORATORIES INC |
| TOLBUTAMIDE | TABLET;ORAL | TOLBUTAMIDE | 500MG | A | 86445 | 1/1/1982 | MYLAN PHARMACEUTICALS INC |
| CALCIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE | INJECTABLE;INJECTION | TPN ELECTROLYTES IN PLASTIC CONTAINER | 16.5MG/ML;25.4MG/ML; 74.6MG/ML;121MG/ML; 16.1MG/ML | N | 18895 | 7/20/1984 | HOSPIRA INC |
| ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE | CAPSULE;ORAL | TREZIX | 320.5MG;30MG;16MG | A | 204785 | 11/26/2014 | WRASER PHARMACEUTICALS LLC |
| CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE | SYRUP;ORAL | TRIACIN-C | 10MG/5ML;30MG/5ML;1.25MG/5ML | A | 88704 | 3/22/1985 | STI PHARMA LLC |
| HYDROCORTISONE ACETATE; UREA | CREAM;TOPICAL | U-CORT | 1%;10% | A | 89472 | 6/13/1988 | TARO PHARMACEUTICALS USA INC |
| TECHNETIUM TC-99M RED BLOOD CELL KIT | INJECTABLE;INJECTION | ULTRATAG | N/A | N | 19981 | 6/10/1991 | MALLINCKRODT NUCLEAR MEDICINE LLC |
| METHOXSALEN | INJECTABLE;INJECTION | UVADEX | 0.02MG/ML | N | 20969 | 2/25/1999 | THERAKOS INC |
| VALRUBICIN | SOLUTION;INTRAVESICAL | VALSTAR PRESERVATIVE FREE | 40MG/ML | N | 20892 | 9/25/1998 | ENDO PHARMACEUTICAL SOLUTIONS INC |
| VANCOMYCIN HYDROCHLORIDE | POWDER;IV (INFUSION) | VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER | EQ 100GM BASE | A | 91532 | 1/6/2016 | SAMSON MEDICAL TECHNOLOGIES LLC |
| EFLORNITHINE HYDROCHLORIDE | CREAM;TOPICAL | VANIQA | 13.90% | N | 21145 | 7/27/2000 | SKINMEDICA INC |
| VASOPRESSIN | SOLUTION;IV (INFUSION) | VASOSTRICT | 20UNITS/ML (20UNITS/ML) | N | 204485 | 4/17/2014 | PAR STERILE PRODUCTS LLC |
| CALCITRIOL | OINTMENT;TOPICAL | VECTICAL | 3MCG/GM | N | 22087 | 1/23/2009 | GALDERMA LABORATORIES LP |
| CLOZAPINE | SUSPENSION;ORAL | VERSACLOZ | 50MG/ML | N | 203479 | 2/6/2013 | JAZZ PHARMACEUTICALS INTERNATIONAL III |
| RIMEXOLONE | SUSPENSION/DROPS;OPHTHALMIC | VEXOL | 1% | N | 20474 | 12/30/1994 | ALCON LABORATORIES INC |
| DOXYCYCLINE CALCIUM | SUSPENSION;ORAL | VIBRAMYCIN | EQ 50MG BASE/5ML | N | 50480 | 1/1/1982 | PFIZER LABORATORIES DIV PFIZER INC |
| TENIPOSIDE | INJECTABLE;INJECTION | VUMON | 10MG/ML | N | 20119 | 7/14/1992 | HQ SPECIALTY PHARMA |
| ETHINYL ESTRADIOL; NORELGESTROMIN | FILM, EXTENDED RELEASE;TRANSDERMAL | XULANE | 0.035MG/24HR;0.15MG/24HR | A | 200910 | 4/16/2014 | MYLAN TECHNOLOGIES |
| STREPTOZOCIN | INJECTABLE;INJECTION | ZANOSAR | 1GM/VIAL | N | 50577 | 5/7/1982 | TEVA PHARMACEUTICALS USA |
| MIGLUSTAT | CAPSULE;ORAL | ZAVESCA | 100MG | N | 21348 | 7/31/2003 | ACTELION PHARMACEUTICALS LTD |
| SUMATRIPTAN SUCCINATE | SOLUTION;SUBCUTANEOUS | ZEMBRACE SYMTOUCH | EQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML) | N | 208223 | 1/28/2016 | DR REDDYS LABORATORIES LTD |
| ZINC CHLORIDE | INJECTABLE;INJECTION | ZINC CHLORIDE IN PLASTIC CONTAINER | EQ 1MG ZINC/ML | N | 18959 | 6/26/1986 | HOSPIRA INC |
| ZOLEDRONIC ACID | SOLUTION;IV (INFUSION) | ZOLEDRONIC ACID | EQ 4MG BASE/100ML (EQ 0.04MG BASE/ML) | N | 204016 | 12/28/2015 | HOSPIRA INC |
| DOXEPIN HYDROCHLORIDE | CREAM;TOPICAL | ZONALON | 5% | N | 20126 | 4/1/1994 | DELCOR ASSET CORP |
| ACYCLOVIR | CREAM;TOPICAL | ZOVIRAX | 5% | N | 21478 | 12/30/2002 | VALEANT INTERNATIONAL BERMUDA |
| ZILEUTON | TABLET, EXTENDED RELEASE;ORAL | ZYFLO CR | 600MG | N | 22052 | 5/30/2007 | CHIESI USA INC |
| LOTEPREDNOL ETABONATE; TOBRAMYCIN | SUSPENSION/DROPS;OPHTHALMIC | ZYLET | 0.5%;0.3% | N | 50804 | 12/14/2004 | BAUSCH AND LOMB INC |
Комментариев нет:
Отправить комментарий